Sort
10,829 grants matching “car t”
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array
$934,299Benjamin Jacob Doranz · Integral Molecular · R44 · FY2020 · GM
Next Generation Immunotherapies for Pediatric Cancers
$932,006Crystal Mackall · Stanford University · R35 · FY2025 · CA
Next Generation Immunotherapies for Pediatric Cancers
$931,841Crystal Mackall · Stanford University · R35 · FY2024 · CA
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
$930,383Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
$929,754Pamela J Skinner · University Of Minnesota · R01 · FY2022 · MH
Non-human Primate (NHP Core)
$929,192James L Riley · University Of Pennsylvania · P01 · FY2025 · AI
Specificity Screening Drug Development Tool for Biotherapeutic Safety
$929,016Benjamin Jacob Doranz · Integral Molecular · SB1 · FY2025 · GM
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
$928,524Jeffrey S Miller · University Of Minnesota · R35 · FY2023 · CA
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
$928,524Jeffrey S Miller · University Of Minnesota · R35 · FY2025 · CA
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$928,184Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
MRI: Development of a Controlled-Trajectory Rapid Compression and Expansion Machine
$927,605Zongxuan Sun · University Of Minnesota-Twin Cities · · FY2014 · ENG
Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity
$925,831Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2019 · ES
Microfluidic CAR-T Cell Processing Device
$924,383Tony Ward · Gpb Scientific, Inc. · R42 · FY2019 · CA
Manufacturing advances to place a powerful form of T cell therapy on the road to commercialization
$923,504John Wilson · Wilson Wolf Manufacturing Corporation · R44 · FY2018 · CA
Low-cost Mobile Oral Cancer Screening for Low Resource Setting
$922,631Rongguang Liang · University Of Arizona · UH3 · FY2018 · CA
Developing Novel Therapies for High Risk Pediatric Cancers
$922,580Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Large Wave Events in a Changing Climate
$922,503Noboru Nakamura · University Of Chicago · · FY2019 · GEO
Strategies to Improve Kaposi's Sarcoma Outcomes in Zimbabwe
$922,408Thomas B. Campbell · University Of Colorado Denver · R01 · FY2014 · CA
Pelvic Pain and Depression
$922,365David J Klumpp · Northwestern University At Chicago · U01 · FY2014 · DK
Pelvic Pain and Depression
$921,959David J Klumpp · Northwestern University At Chicago · U01 · FY2016 · DK
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
$921,486Joana M Murad · Celdara Medical, Llc · R44 · FY2024 · NS
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
$921,394Joana M Murad · Celdara Medical, Llc · R44 · FY2025 · NS
Human Monoclonal Antibodies Against Cancer
$920,549Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
High Throughput & Quantitative Cell Purification for ImmunotherapyManufacture
$920,268Coleman Murray · Ferrologix, Inc. · R44 · FY2020 · CA
Regulation of innate lymphocyte function
$919,783Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI